Travis Perkins says outlook uncertain due to inflation

0

Travis Perkins announced its Q1 trading update on Friday where the group said its recorded an encouraging first quarter which reflects the group’s strategic progress and voiced its concerns regarding material inflation resulting in an uncertain outlook for 2022.

Travis Perkins reported total sales for the first quarter of 2022 were 13.6% higher than in 2021, indicating a solid start to the year for the group.

Total sales increased 17.9% in the Merchanting area, with all businesses functioning in line with expectations, owing almost two-thirds of the rise to pricing as manufacturers continued the raises which will be passed through promptly.

The queue of social and economic infrastructure development, as well as the continued need for additional homes, continue to support strong customer demand across all end markets for Travis Perkins.

SME customers’ order books are still solid, with a growing interest in energy efficiency projects says the group.

Travis Perkins’ Toolstation total sales fell 6.0% in the first quarter, with LFL sales falling 11.9%, reflecting a difficult prior-year comparator and the return of Toolstation’s customer mix to its core trade base, which continues to realise the importance and convenience of the customer proposition.

As the comparison period passes the elimination of pandemic limitations leaves management to be hopeful that business drivers will normalise in the second half of the year.

By the end of 2021, the construction supply chain had mostly normalised, and while the crisis in Ukraine and its influence on the global economy may threaten that relative stability, the group’s stock levels remain robust.

The group’s outlook for materials price inflation, which was previously projected to moderate towards the second half of the year, is now more uncertain, with pricing likely to account for a larger share of sales growth throughout the year than previously anticipated.

Overall, Travis Perkins’ cost inflation is expected to be moderate.

Despite the current uncertain financial and geopolitical environment, order books in the construction industry in the United Kingdom remain strong.

Management’s full-year projections remain unchanged, owing to Travis Perkins’ stable end markets and trade-focused business strategy.

Nick Roberts, Chief Executive Officer, Travis Perkins, commented, “The Group has had an encouraging first quarter and, although the wider economic backdrop remains uncertain, we are well placed to build on this positive start in the coming months.”

“The energy efficiency of the UK’s built environment remains a key focal point for households and politicians alike and the current cost of energy is likely to prompt further demand for improvement in both new and existing buildings. Allied to the significant pipeline of investment in the UK’s social and economic infrastructure, we remain confident in the structural drivers of demand in our end markets.”

“As the UK’s largest building materials supplier and a leading partner to the construction industry, we are uniquely placed to support the country in this drive and are working closely with all key stakeholders, including government, housebuilders, tradespeople and developers, to address these challenges.”

Travis Perkins shares dropped 1.4% to 1,249p on Friday despite the group stating that the start of 2022 was encouraging in its Q1 trading update.

Computacenter shares dip 4% despite top-line growth

0

Computacenter shares dipped 4.2% to 2,623p despite the company announcing that its top-line grew strongly in the first quarter of 2022 on Friday.

Computacenter saw its top line grow strongly in the first quarter of 2022, as planned, but adjusted profit before tax grew more modestly, owing to one extremely large volume customer diluting our overall margin.

Furthermore, the significant elimination of lockdown measures in the areas where the group operates has resulted in a return to a more normal, and more sustainable, cost base post-COVID-19.

As Computacenter reported at the time of its final results, H1 2021 presented a more difficult comparison than the entire year, so being profitable ahead of 2021 after the first quarter is encouraging.

Computacenter Outlook

Although adjusted profit before tax at the end of H1 2022 will likely be lower than in 2021, Computacenter will still be operating in line with its business’s historical seasonality, giving the group confidence for the entire year even though much work remains to be done.

The group is optimistic that FY 2022 will be a year of continued improvement and Computacenter is currently on target for the entire year.

There are certainly numerous issues in the world, and the business, like most firms, is affected by wage inflation and supply chain limitations. However, these challenges provide Computacenter with the opportunity to differentiate itself from the competitors by providing superior execution.

The momentum that Computacenter has developed over many years, as well as the solidity of its balance sheet, invoked confidence in the group’s future and the group said its next scheduled trading update is its Interim Results, which will release on 9 September 2022.

Pearson reports underlying sales growth of 7%

2

Pearson continued the momentum with underlying sales growth of 7% in the first quarter of 2022 and acquired Mondly in English Language Learning said the group on Friday.

Pearson reported an underlying sales growth of 7% in the first quarter of 2022 with Sales of Assessment & Qualifications contributing 22%.

The group’s Sales of Assessments & Qualifications increased by 22% across the board. The outstanding performance of the US Student Assessment can be attributed in part to the normalisation of exam schedules and Clinical Assessment performed admirably, thanks to the phasing of orders.

Pearson enjoyed a strong retention rate in Virtual Schools and growth in OPM helped boost Virtual Learning sales by 3%, where the OPM contract with ASU will expire in June 2023, as revealed on April 19th.

Borders re-opening and improved worldwide mobility boosted English Language Learning revenues by 18% in Q1, with growth in Pearson Test of English volumes weighted to Q1.

Higher Education revenues fell 5% due to predicted declines in US higher education, indicating a continuous decline in enrolments and courses per enrolment for the academic year 2021/22.

Pearson’s GED Testing Service was chosen as an education partner for Amazon’s Career Choice initiative, indicating that the company has made significant strategic development.

Sales of Workforce Skills increased by 9% excluding acquisitions, owing to continued growth in BTEC, GED, and TalentLens for Pearson, and as projected, sales in enterprises undergoing strategic review dropped 11%.

The group also reported a share buyback programme to return £350m to shareholders and stated that the first tranche commenced in April, of which over £75m had already been completed.

Pearson reaffirmed its guidance for adjusted operating profit in 2022.

Pearson acquires Mondly

Pearson announced the acquisition of Mondly, which was a strategic purchase for the English Language Learning division, today.

The acquisition is another step forward in the digital strategy, providing the group with access to the rapidly expanding direct to consumer English language learning sector.

Institutional, Pearson Test of English, and Workforce Skills are all strategic growth areas for Pearson, with synergies and cross-selling opportunities.

Pearson expects mid-teens margins for the division by 2025.

Andy Bird, Chief Executive Officer, Pearson said, “Pearson has continued to make strong strategic, operational and financial progress through the first quarter. Underlying sales grew by 7%, and we remain on track to deliver on our 2022 financial expectations and medium-term guidance.” 

“Our acquisition of Mondly, one of the world’s leading online language learning platforms, is another exciting strategic development. It strengthens Pearson’s direct to consumer strategy and supports our ambition to become the global leader in English language learning for committed learners.” 

“We remain sharply focused on the successful execution of our strategy and we are encouraged by the momentum we are seeing across the business.”

Pearson shares gained 2.6% to 791p on Friday after the group reported its Q1 trading update.

AstraZeneca revenues increase 60%, Covid-19 treatments decline

0

AstraZeneca shares fell 0.3% to 10,522p in early morning trading on Friday, following the group’s reported 60% increase in revenue to $11.3 billion in Q1 2022.

The pharmaceutical company attributed its growth to the contribution of the Alexion medicines and multiple Vaszevria contracts, which are set to complete delivery by HY1 2022.

“AstraZeneca’s product portfolio’s had a boost from its Alexion acquisition and that’s helped the group surpass revenue expectations,” said Hargreaves Lansdown equity analyst Laura Hoy.

The firm highlighted a 25% in total revenue from oncology, with department product sales gaining 18%, a total revenue from cardiovascular, renal and metabolism (CVRM) rise of 18%, respiratory and immunology (R&I) enjoying a 4% boost and rare disease rising 7% across Q1.

Astra announced a core earnings per share increase of 20% to $1.89, and noted that its operating margin benefitted from phasing of costs.

However, Astrazeneca mentioned its EBITDA fell 16% to $2.2 billion, reporting below analyst expectations as a result of a $1.2 billion charge linked to the revaluation of Alexion’s inventory, alongside a 36% increase in research and development costs.

The group mentioned that core operating expenses were likely to increase by the low-to-mid teens percentage across the coming term due to costs including the full-year integration of Alexion expenses.

The firm estimated revenue from Covid-19 medicines would also decline by approximately 20-25%, with the gross margin from coronavirus treatments projected to be lower than the company average.

Astrazeneca added that its expected decline in Vaxzevria sales would probably be slightly offset by growth in Evusheld sales.

“2022 has started strongly for AstraZeneca. Farxiga achieved $1bn revenue in the quarter and our Oncology medicines delivered Product Sales growth of 18%, despite COVID-19 continuing to impact cancer diagnosis and treatment,” said AstraZeneca CEO Pascal Soriot.

“High-level results from the DESTINY-Breast04 trial pointed to Enhertu’s potential to redefine treatment of HER2‑low metastatic breast cancer, and Ultomiris became the first and only long-acting C5 inhibitor approved for generalised myasthenia gravis in the US.”

“Our investments in pioneering science give us confidence of further advances in the years to come.”  

Reckitt Benckiser enjoys 5.6% LFL revenue boost

0

Reckitt Benckiser shares increase 1.4% to 6,300p in early morning trading on Friday, after the consumer goods firm reported a 5.6% boost in total net revenue to £3.4 billion in like-for-like sales in its Q1 2022.

The group said it attributed its growth to continued broad-based growth and market share momentum across all businesses and territories, with 76% of its core category market units either gaining or holding market share.

However, Reckitt Benckiser saw its reported total net revenue fall 2.3%, with hygiene falling 10.7% and nutrition dropping 14.8%.

The firm reported a 15.8% reported gain in health as a result of an increase in OTC, VMS and Intimate Wellness growth, with a 20.6% uptick to £1.4 billion on a like-for like basis.

The company also saw a 20.4% rise to £557 million for nutrition on a like-for-like basis linked to a 30% US IFCN growth with strong execution, despite the hurdle of temporary competitor supply problems.

However, the firm experienced a 9% drop in like-for-like sales across its hygiene department, despite noted gains in its Finish, Air Wick, Harpic and Vanish brands as a result of the company’s penetration building initiatives.

The company also confirmed the ongoing offloading of its Russian arm, which it said might include a transfer to a third party or to local employees, moving on from the firm’s decision earlier in the year to freeze all capital investments and marketing in the country after the Ukrainian invasion on 24 February.

Reckitt Benckiser said 70% of its portfolio less sensitive to Covid-19 dynamics grew in the high-single digits.

The group added that its outlook estimated a 1-4% like-for-like net revenue growth at the upper end of management expectations, with adjusted operating margins in line with the previous year and current executive projections, despite significant cost inflation across the board.

“We have made a strong start to the year across all our business units and geographies despite a challenging operating environment.  Investments we have made in brand building, innovation, and execution, have resulted in broad-based market share gains.  These, coupled with pricing and revenue management actions, stand us in good stead to maintain this positive momentum,” said Reckitt Benckiser CEO Laxman Narasimhan.    

“As we look to the balance of the year, the operating environment remains highly unpredictable.  We are well placed to address these market dynamics through the strength of our brands, our favourable product mix, our productivity program and the responsible pricing initiatives already undertaken, with scope to take further actions.”  

“Given our strong start, we expect to deliver LFL net revenue growth at the upper end of our guidance for the year. We expect adjusted operating margins to be in-line with both the prior year and current market expectations, whilst continuing to invest in the long-term growth of our brands.” 

Advanced Oncotherapy: Technical to Commercial by Summer

0

Advanced Oncotherapy (AVO) 24p Mkt Cap £110m* Last Summer we reported the £40m fund raise at 40p needed to complete the technical development stage of its world leading Proton Beam Therapy LIGHT system. The recent trading update includes a video showing how the system will work.  After seven years of development, it is expected that the last technical milestone will be completed this summer. The delay from last year’s best expectations was primarily due to regulatory verification hurdles as it concurrently seeks FDA and CE Marking approval.
The technology behind it is from CERN,...

Novacyt shares fall on £181m revenues drop

0

Novacyt shares were down 5.1% to 152p in late afternoon trading in light of the firm’s total revenue drop to £95.8 million in 2021 compared to £277.2 million in 2020, excluding £40.9 million of 2021 DHSC revenue under contractual dispute.

The company announced an 86% revenue allocation linked to Covid-19 products, compared to 95% in the year before.

Novacyt confirmed a shift away from large, centralised contracts towards independent testing, with a focus on private laboratories and non-governmental organisations (NGOs).

The group reported a 98% revenue increase to £55.9 million from £28.3 million year-on-year on private laboratory revenues, including £10.5 million from NGOs.

The company said private testing made up 58% of 2021 revenues at £55.9 million, against 10% in 2020 of £28.3 million.

The UK contributed to a reported 45% of total revenues with £42.7 million compared to 79% in 2020 at £219.4 million.

The company mentioned a gross profit of 68% at £65.4 million, representing a decline from its 76% result in 2020 due to a higher stock provision on an obsolescence of Covid-19 products as the pandemic eased, alongside margin dilution as a result of increased instrument sales as the firm built its installed base.

Novacyt confirmed a cash position of £101.7 million on 31 December 2021 against £91.8 million the previous year, with the company remaining debt free heading into 2022.

“In 2021, we delivered a financial performance in line with market expectations. The Company responded to a rapidly changing marketplace and diversified from predominately servicing government COVID-19 testing tenders, to the private market for COVID-19 testing in travel, sport, film, media, and workplace settings,” said Novacyt CEO David Allmond.

“Novacyt’s reputation for the innovation and high performance of its diagnostic technologies was reinforced throughout the pandemic and the Company has established a strong foundation of R&D, manufacturing, regulatory and commercial capabilities, supported by a strong financial position.”

“As a result, Novacyt is well positioned for future growth and value creation and there are exciting times ahead for the Company as we move past the current pandemic   and continue our journey to become a leading global clinical diagnostics company focused on unmet needs in infectious diseases.”

SAE shares soar 15% on Uskmouth site transition

0

Simec Atlantis Energy (SAE) announced on Thursday that its Uskmouth site is transitioning into a sustainable energy park, leading the group’s shares to soar 15% to 2.65p.

SAE said that the Uskmouth site’s transformation into a sustainable energy park includes plans to provide a Battery Energy Storage System as a first step (BESS).

The Uskmouth site has a 230MW grid connection, as well as extensive land and infrastructure, making it an ideal location for the construction of a large-scale, commercially appealing BESS project.

BESS integration into transmission and distribution networks is widely acknowledged as a significant enabler of increased and faster integration of intermittent renewable energy into the UK electricity supply.

SAE has progressed the BESS development process by submitting a Modification Application to National Grid, requesting that the Uskmouth site’s connection agreement be changed to accommodate a BESS plant.

SAE has also filed a screening report to Newport City Council for the development of a 230MW BESS facility on the former coal stockyard and is working with an industry-leading partner to expedite the battery storage facility’s delivery.

SAE is no longer pursuing the previously stated plans for the Uskmouth Conversion Project due to the establishment of a BESS at the Uskmouth site and has notified Welsh Government and relevant stakeholders that it would be withdrawing the permission variation application.

SAE has entered into a deal to sell some parts of the plant that are no longer needed for the site’s future ambitions as a result of this decision.

Wye Valley Demolition, a local company, has been given £1.2m contracts to remove the redundant plant and equipment.

This deal provides immediate funding to SAE’s business, assisting in the achievement of SAE’s broader goals and providing value to shareholders.

While SAE will not move through with the Uskmouth Conversion Project, the need to repurpose coal-fired power plants has never been greater to decrease emissions, improve energy security, and reduce waste shipped to landfills and polluting our oceans.

Governments throughout the world are looking for projects that can provide energy security and independence rapidly, and our coal plant conversions can provide a speedy and cost-effective solution.

SAE is committed to expediting the transition of existing coal-fired power plants to lower-emissions fuels and is working with its partners to transfer key lessons learned to other nations where they may have the most impact.

Graham Reid, CEO of SAE commented, “The team and I are tremendously excited about this next step for the Uskmouth site, which will help deliver the UK’s net zero targets, release important value for the business and allow the team to build on the lessons learnt to help countries around the world to achieve the targets of reducing reliance on coal, increasing energy security, and finding long term solutions to the growing waste problem.”

Argo Blockchain mines 2,033% income spike

1

Argo Blockchain shares were up 7.6% to 65.6p in late afternoon trading on Thursday, after the cryptocurrency mining group reported a 291% rise in revenue to £74.2 million in 2021 compared to £19 million the previous year.

The company attributed its surge in revenues to a significant uptick in its hashrate, alongside a short-term fall in difficulty on the Bitcoin network and raised Bitcoin prices in 2021.

Argo Blockchain highlighted a 594% spike in EBITDA to £52.9 million against £7.6 million the previous year, and a 2,033% jump in delivered net income to £30.8 million compared to £1.4 million.

The group said its mining margin rose to 84% against 41% in 2020, which was driven by the increased price of Bitcoin following the Chinese ban on Bitcoin mining in May 2021.

The firm noted cash and digital assets of £92.6 million based on the Bitcoin price on 31 December 2021.

Argo Blockchain also reported a 17% decline to 2,045 in the total number of Bitcoin mined, which it linked to the halving event in May 2020 which reduced the block award from 12.5 to 6.25 Bitcoin per block.

The company added that it held 2,700 Bitcoin and Bitcoin equivalents valued at £93.6 million per the Bitcoin price on 31 May 2022.

Operational developments and Acquisitions

Argo Blockchain acquired the Helios project in Texas, which has an interconnection agreement for 800 mega-watts of power capacity, with the company anticipating phase one’s initial 200 mega-watts ready for operation in May 2022.

The firm also acquired two data centres in Quebec from GPUone, with combined total of 20 mega-watts in power capacity.

The crypto company further said it had acquired 20,000 Bitmain S19J Pro mining machines, with delivery and installation expected to commence in batches between May to October this year.

Argo Blockchain added that it expanded its Bitcoin mining capacity from 0.6 to 1.6 Exahash per second.

Argo growth for 2022

The firm said it expects mining operations to commence at Helios in May 2022, with additional capital spending to complete Helios phase one to amount to £93-£100 million, which is set to be financed primarily through debt and income from selling a portion of mined Bitcoin per month.

The company added that it projected a 5.5 Exahash per second capacity by the close of 2022, driven by the installation of the Bitmain S19J Pro machines alongside the deployment of custom-designed mining machines which would utilise Intel’s ASIC Blockscale chips.

Argo noted an estimated hashrate in excess of 20 exahash per second over the next few years as the additional 600 mega-watts of Helios capacity is completely developed.

“2021 was truly a year of transformation for Argo as we accomplished key milestones to strengthen the foundation of the Group and position us for long-term success through the acquisition of the Helios project and our dual listing on Nasdaq,” said Argo Blockchain CEO Peter Wall.

“The acquisition of Helios provided us with the opportunity to build a best-in-class, vertically-integrated facility with access to low-cost and sustainable electricity, which is unmatched by our peers.”

“With our mining operations at Helios expected to commence in May, along with the development of custom mining machines using Intel’s next-generation Blockscale ASIC chips, Argo is well-positioned to continue its growth with a focus on delivering for our shareholders. Onwards and upwards.” 

US GDP faces unexpected contraction of 1.4%

0

The US Commerce Department said on Thursday that US GDP fell by 1.4% on an annualised basis in the first quarter, indicating a sharp reverse for an economy due to a rebound in Covid-19 cases which interrupted activity.

The first quarter of US economic growth unexpectedly decreased by 1.4% as a rebound of COVID-19 cases interrupted activity, yet the drop in output creates a mixed picture of the economy amid strong domestic demand.

Rising omicron infections slowed activity across the board at the start of the year, inflation spiked to levels not seen since the early 1980s and the Russian invasion of Ukraine added to the economic stalemate which hamped economic growth in some nations.

The 1.4% decline in US GDP was the first drop in nearly two years, following the pandemic recession. In the fourth quarter of 2021, the economy expanded at a solid 6.9% rate.

Economists polled by Reuters had forecast the economy growing at a 1.1% rate and Dow Jones predicted a 1% increase in GDP for the quarter, both were missed by the negative growth rate.

While the reports may elicit shrieks of stagflation and recession from some quarters, it does not accurately reflect the economy.

The slowdown in growth was caused by a reduction in private inventory investment, which had fueled growth in the second half of 2022.

A 3.2% trade deficit and a slower-than-expected inventory buildup, exports and government spending across state, federal, and local governments, as well as increased imports, were further constraints and lead to a drop in GDP.

As a result, a measure of domestic demand excluding trade, inventories, and government spending increased sharply from 2.6% in the fourth quarter, approximately 85% of total spending is spent on final sales to private domestic buyers.

Defence spending cuts of 8.5% were a significant drag, wiping a third of a percentage point off the final GDP figure.

As part of its fight against inflation, the Federal Reserve hiked its policy interest rate by 25 basis points in March, the first increase in more than three years.

In March, annual consumer prices rose at their fastest rate in 40 years. Despite rising food and gasoline prices, there is little evidence that consumers are pulling back.

Consumer spending increased by 2.7% in the quarter, despite continued price pressure from inflation.

Next Wednesday, the Federal Reserve is likely to raise interest rates by 50 basis points and begin reducing its asset holdings said Reuters.

The Labor Department released separate data on Thursday indicating that initial applications for state unemployment benefits declined 5,000 to a seasonally adjusted 180,000 for the week ending April 23. This reflected improving labour market conditions.

Strong wage growth despite a tightening job market, as well as at least $2tr in surplus savings collected during the pandemic, are helping to keep inflation at bay.

Lower-income customers, who are disproportionately hit by inflation, were displaying stronger resilience, according to Bank of America Securities data.

Nevertheless, there are concerns that the Fed may tighten monetary policy too quickly and send the economy into recession during the next 18 months. The 30-year fixed mortgage has risen beyond 5%, indicating that the property market is already declining.

While most economists believe the United States will avoid a full-fledged recession as risks are increasing, a lot depends on how quickly geopolitical tensions and supply chains dissipate, as well as whether or not inflation falls.